摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-[(4-chlorophenyl)methylidene]-2-hydroxybenzohydrazide | 18176-37-9

中文名称
——
中文别名
——
英文名称
N'-[(4-chlorophenyl)methylidene]-2-hydroxybenzohydrazide
英文别名
2-hydroxybenzoic acid (4-chlorobenzylidene)hydrazide;N'-(4-chlorobenzylidene)-2-hydroxybenzohydrazide;N-(4-chlorobenylidene)-2-hydroxbenzohydrazide;salicylic acid-(4-chloro-benzylidenehydrazide);Salicylsaeure-(4-chlor-benzylidenhydrazid);4-Chlor-benzaldehyd-salicyloylhydrazon;N-[(4-chlorophenyl)methylideneamino]-2-hydroxybenzamide
N'-[(4-chlorophenyl)methylidene]-2-hydroxybenzohydrazide化学式
CAS
18176-37-9
化学式
C14H11ClN2O2
mdl
——
分子量
274.707
InChiKey
HNHWDPXSZPBROS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.7
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N'-[(4-chlorophenyl)methylidene]-2-hydroxybenzohydrazide 反应 1.0h, 生成 3-N-acetyl-5-[2-acetoxyphenyl]-2-(4-chlorophenyl)-2,3-dihydro-1,3,4-oxadiazole
    参考文献:
    名称:
    Formation of 1,3,4-oxadiazolines and 1,3,4-oxadiazepines through acetylation of salicylic hydrazones
    摘要:
    A new series of 1,3,4-oxadiazolines and 1,3,4-oxadiazepines are prepared in a one-step reaction through cyclization of various N-benzylidene-2-hydroxybenzohydrazides. Cyclization in acetic anhydride yielded 1,3,4-oxadiazolines, while the reaction carried out in acetic anhydride-acetic acid gave 1,3,4-oxadiazepines, in some cases. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2014.12.037
  • 作为产物:
    描述:
    水杨酸甲酯一水合肼溶剂黄146 作用下, 以 乙醇 为溶剂, 反应 15.0h, 生成 N'-[(4-chlorophenyl)methylidene]-2-hydroxybenzohydrazide
    参考文献:
    名称:
    水杨酸肼的某些杂环化合物的合成及生物评价
    摘要:
    从2-羟基苯甲酰肼开始制备了各种杂环化合物;例如,酰肼腙环化3由2- hydroxybenzohydrazide衍生2用乙酸酐或浓硫酸,得到1,3,4-恶二唑衍生物4 - 5。在另一方面,2-羟基苯甲酰肼的环化直接2与一个碳环化剂得到的1,3,4-恶二唑的新衍生7,8,9,10,11。用吡啶中的巯基乙酸对酰肼3进行加热,得到噻唑烷酮12。当2-羟基苯甲酰肼2与脂肪族羧酸(例如甲酸或乙酸)反应时,得到相应的N-甲酰基或N-乙酰基衍生物6。随后在吡啶中使用五硫化二磷对6进行环化,得到1,3,4-噻二唑13。2-羟基苯并肼与乙酰乙酸乙酯的环化反应得到吡唑啉酮衍生物14。最后,当在35%HCl中用硫氰酸铵处理酰肼2的乙醇溶液时,得到硫代氨基脲15。后续治疗15用浓硫酸或10%氢氧化钠溶液分别制得5-氨基-1,3,4-噻二唑16和1,2,4-三唑17。使用1 H NMR,IR光谱和元素分析确认了所有
    DOI:
    10.1002/jhet.2516
点击查看最新优质反应信息

文献信息

  • Synthesis of some Schiff base Derivatives using One pot Grinding Method and Its Biological activities
    作者:Anusuya V Anusuya V、Muruganantham N Muruganantham N、Anitha P Anitha P、Mahesh S Mahesh S
    DOI:10.13005/ojc/380626
    日期:2022.12.30

    In this present study, we reported the synthesis of some Schiff base derivatives by one pot grinding method from 2-hydroxy benzohydrazide and Aromatic aldehydes. NMR and IR spectroscopy were used to characterize the synthesized compounds. The antioxidant, antidiabetic and anti-inflammatory properties of the Schiff base derivatives 3(a-j) were studied. Regarding standards, all the compounds demonstrated good biological activity.

    在本研究中,我们报告了用一锅研磨法从 2-hydroxy benzohydrazide 和芳香醛中合成了一些希夫碱衍生物。核磁共振和红外光谱用于表征合成的化合物。研究了希夫碱衍生物 3(a-j)的抗氧化、抗糖尿病和抗炎特性。根据标准,所有化合物都具有良好的生物活性。
  • 10.1016/j.tube.2024.102545
    作者:Ieque, Andressa Lorena、Palomo, Carolina Trevisolli、Gabriela de Freitas Spanhol, Vitória、Fróes da Motta Dacome, Maria Luiza、Júnior do Carmo Pereira, José、Candido, Francielli Cavalcante、Caleffi-Ferracioli, Katiany Rizzieri、Dias Siqueira, Vera Lucia、Cardoso, Rosilene Fressatti、Vandresen, Fábio、Alves-Olher, Vanessa Guimarães、de Lima Scodro, Regiane Bertin
    DOI:10.1016/j.tube.2024.102545
    日期:——
    This study target the synthesis of 22 salicylhydrazones derivatives to apply screening to explore their potential in the search for new anti-TB prototypes drugs. The minimum inhibitory concentration (MIC) were evaluated against () HRv and clinical isolates. Drug combination assay, cytotoxicity assay, ethidium bromide accumulation assay (EtBr) and analysis regarding the absorption, distribution, metabolism
    本研究的目标是合成 22 种水杨酰腙衍生物,并进行筛选,探索其在寻找新的抗结核原型药物中的潜力。针对 () HRv 和临床分离株评估最低抑菌浓度 (MIC)。还进行了药物组合测定、细胞毒性测定、溴化乙锭累积测定(EtBr)以及吸收、分布、代谢、排泄和毒性(ADMET)和药理特性分析。选择了三种最有希望的化合物(10、11 和 18)进行筛选测试。化合物 18 对 HRv 菌株的 MIC 值最低 (0.49 μg/mL),其次是化合物 11 (3.9 μg/mL) 和 10 (7.8 μg/mL)。所有化合物均表现出针对药物敏感和耐药临床分离株的活性。所有水杨酰腙的细胞毒性结果都令人鼓舞,化合物 18 的 SI 值高达 4,205。衍生物 10 是唯一一种对单细胞系表现出不乐观的细胞毒性情况的化合物。所有衍生物与异烟肼、乙胺丁醇和利福平联合显示出相加效应(FICI>0.5至4.0)。所有水杨
  • Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1
    作者:Joseph J. Jablonski、Dipwanita Basu、Daniel A. Engel、H. Mario Geysen
    DOI:10.1016/j.bmc.2011.10.026
    日期:2012.1
    Influenza is a continuing world-wide public health problem that causes significant morbidity and mortality during seasonal epidemics and sporadic pandemics. The existing vaccination program is variably effective from year to year, and drug resistance to available antivirals is a growing problem, making the development of additional antivirals an important challenge. Influenza virus non-structural protein 1 (NS1) is the centerpiece of the viral response to the host interferon (IFN) system. NS1 was demonstrated previously to be a potential therapeutic target for antiviral therapy by the identification of specific small-molecule inhibitors. One inhibitory compound, NSC125044, was subjected to chemical evaluation. Initial synthetic work comprised simplifying the core structure by removing unwanted functionality and determination of key features important for activity. Several subclasses of molecules were designed and synthesized to further probe activity and develop the basis for a structure-activity relationship. Apparent potency, as judged by activity in virus replication assays, increased dramatically for some analogs, without cytotoxicity. Results suggest that the target binding site tolerates hydrophobic bulk as well as having a preference for weakly basic substituents. (C) 2011 Elsevier Ltd. All rights reserved.
  • Anusuya; Sujatha; Balaji, European Journal of Molecular and Clinical Medicine, 2020, vol. 7, # 9, p. 1760 - 1769
    作者:Anusuya、Sujatha、Balaji
    DOI:——
    日期:——
  • NOVEL METHODS FOR THE PREPARATION OF BENZISOTHIAZOLONES. 2-BENZALAMINOBENZISOTHIAZOLONES
    作者:LEON KATZ、WILLIAM SCHROEDER
    DOI:10.1021/jo01366a017
    日期:1954.1
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐